Evidence map›Paper›PMID 36072693›Full record

ArticleInternational journal of women's health2022

Knowledge, Barriers and Motivators to Cervical Cancer Screening in Rwanda: A Qualitative Study.

Jean Pierre Gafaranga, Felix Manirakiza, Emmanuel Ndagijimana, Jean Christian Urimubabo, Irénée David Karenzi, Esperance Muhawenayo, Phophina Muhimpundu Gashugi, Dancilla Nyirasebura, Belson Rugwizangoga

Open access · goldAbstract read
In one paragraph

Article in International journal of women's health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jean Pierre GafarangaDepartment of Psychiatry, School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda.ORCID 0000-0001-7528-4667
Felix ManirakizaDepartment of Clinical Biology, School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda.ORCID 0000-0002-9143-8758
Emmanuel NdagijimanaDepartment of Epidemiology and Biostatistics, School of Public Health, University of Rwanda, Kigali, Rwanda.
Jean Christian UrimubaboDepartment of Surgery, University Teaching Hospital of Kigali, Kigali, Rwanda.
Irénée David KarenziDepartment of Surgery, Ruhengeri Referral Hospital, Musanze, Rwanda.
Esperance MuhawenayoDepartment of Surgery, University Teaching Hospital of Kigali, Kigali, Rwanda.
Phophina Muhimpundu GashugiDepartment of Physical Rehabilitation, University Teaching Hospital of Kigali, Kigali, Rwanda.
Dancilla NyiraseburaDepartment of Surgery, University Teaching Hospital of Kigali, Kigali, Rwanda.
Belson RugwizangogaDepartment of Clinical Biology, School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda.ORCID 0000-0001-6941-7320
Centre Hospitalier Universitaire de Kigali · RWUniversity of Rwanda · RWINES-Ruhengeri · RWUniversity of Kigali · RW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cervical cancer is a global public health problem with marked geographical disparity. High morbidity and mortality rates in developing countries are associated with low screening rates. In 2020, in Rwanda, 3.7 million women aged 15-59 years were at risk of developing cervical cancer, the most commonly diagnosed female cancer in Rwanda. Despite Rwanda being the first African country to vaccinate against Methods: We conducted a qualitative descriptive study; using focus group interview in an urban health facility (Muhima district hospital) and a rural health center (Nyagasambu health center) offering cervical screening services in Rwanda. Participants were women seeking these services and other women attending the health facility for any reason, and female staff working in these facilities. Interviews were recorded and transcribed, and data were analyzed using content analysis. Results: Thirty women participated in focus group interview, with an average age of 39 years. Many of women showed knowledge about cervical cancer existence and prevention methods. However, fear for pain, lack of knowledge about screening, how and where the screening was done, and concern for privacy were recurring subthemes. Some participants also mentioned lack of health insurance as a barrier for cervical cancer screening. Conclusion: Barriers to uptake cervical cancer screening services in Rwanda are related to poor information about cervical cancer and the importance of screening as well as non-adherence to medical insurance. Population sensitization through campaign and community outreach activities could have a positive impact on increasing the usage of cervical cancer screening in Rwanda.

Indexed as

acceptancecervical cancerfear for painqualitativeRwandascreening

Identifiers

PMID36072693
PMCPMC9443995
OpenAlexW4294325370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.